Clinical trial
Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate…
NCT00037102 · MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute, Other · Completed
Key facts
| NCT number | NCT00037102 |
|---|---|
| Title | Combination Therapy With Avonex and BiMonthly High Dose Intravenous Methotrexate in Multiple Sclerosis |
| Official title | An Open Label Study of the Safety and Efficacy of Combination Therapy With AVONEX and Bi-Monthly High Dose Intravenous Methotrexate With Leucovorin Rescue in the Treatment of Multiple Sclerosis |
| Acronym | MTX01 |
| Lead sponsor | MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute, Other |
| Collaborators | Consultants in Neurology Industry Biogen |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Multiple Sclerosis |
| Intervention type | Drug |
| Interventions | interferon beta 1a, methotrexate |
| Enrollment | 16 |
| Start date | Jul 1, 2001 |
| Primary completion | Dec 1, 2003 |
| Completion | Dec 1, 2003 |
| First posted | May 17, 2002 |
| Last update posted | Apr 12, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: